Major Events - Angli Education plans to sell 100% equity of Kensington Park School Limited for £80,000 (approximately 760,100 RMB) to Hong Kong KS Education Group Limited to alleviate operational difficulties and reduce financial impact [1] Regulatory Actions - Haohai Biological's controlling shareholder, Jiang Wei, received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) for suspected insider trading, which does not impact the company's daily operations or finances [2] - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate information disclosure in its 2015 annual report, involving former executives who are now subject to administrative measures [3] Corporate Actions - Yaoshi Technology announced that the last day for conversion of Yaoshi convertible bonds is September 17, after which unconverted bonds will be forcibly redeemed at 100.62 RMB per bond, potentially leading to investment losses for investors [4] - Kanghui Pharmaceutical intends to change its stock abbreviation from "Kanghui Pharmaceutical" to "Kanghui Co., Ltd." [5] Strategic Partnerships - Jiuzhou Yitu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [6] - Luxiao Technology's subsidiary signed a strategic cooperation agreement to jointly develop AI service robots for the U.S. and European markets, aiming to sell at least 1 million units between 2026 and 2028 [6] - China Shipbuilding Technology signed a green methanol sales contract worth approximately $40 million per year, with potential increases based on customer demand, starting supply in 2028 [6] - Haon Automotive received a product designation notice for ADAS perception systems and radar systems, estimating total revenue of approximately 2.477 billion RMB over a 5-year project lifecycle, with mass production expected to start in April 2026 [6] Shareholding Changes - Medi Technology's shareholder, Weng Kang, plans to reduce his stake by up to 1.7% of the company's total shares, while another shareholder, Wu Di, intends to reduce his holdings by up to 0.0047% [7] - Xinhua Co., Ltd.'s director, Fang Junwei, plans to reduce his holdings by up to 75,200 shares, representing no more than 0.039% of the company's total shares [7]

减持计划详情 翁康拟在2025年10月16日至2026年1月15日期间，通过大宗交易方式减持不超过521.425万股，即不超过 其持有公司股份总数的25%，不超过公司总股本的1.7024%；以集中竞价方式减持不超过306.2827万 股，即不超过其持有公司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过521.425万 股。若减持计划期间公司有送股、资本公积金转增股本等股份变动事项，拟减持股份数量将相应调整。 吴镝拟在同一时间段内，通过大宗交易、集中竞价交易减持不超过1.425万股，即不超过其持有公司股 份总数的25%，不超过公司总股本的0.0047%。若减持计划期间公司有送股、资本公积金转增股本等股 份变动事项，拟减持股份数量也将相应调整。 登录新浪财经APP 搜索【信披】查看更多考评等级 9月17日，苏州麦迪斯顿医疗科技股份有限公司（以下简称"麦迪科技"）发布股东减持股份计划公告， 股东翁康、吴镝因个人资金安排，拟在公告十五个交易日后的三个月内减持公司股份。 减持主体情况 截至本次减持计划实施前，翁康持有麦迪科技2085.7003万股，占公司股本总数的6.8097%，股份来源于 IPO前取得。 ...

人民财讯9月16日电，麦迪科技（603990）9月16日晚间公告，公司股东翁康持有公司6.8097%股份。股 东吴镝持有公司0.0186%股份。翁康拟合计减持公司不超过521.43万股股份，即不超过公司总股本的 1.7%，吴镝拟以大宗交易、集中竞价交易择机减持其所持公司股份不超过1.43万股，即不超过其持有公 司股份总数的25%，不超过公司总股本的0.0047%。 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2025-061 苏州麦迪斯顿医疗科技股份有限公司 重要内容提示： 大股东及董监高持股的基本情况 截至本次减持计划实施之前，苏州麦迪斯顿医疗科技股份有限公司（以下简 称"公司"）股东翁康先生持有公司股份 20,857,003 股，占公司股本总数的 6.8097%。吴镝先生持有公司股份 57,000 股，占公司股本总数的 0.0186%。 减持计划的主要内容 翁康先生拟在本计划公告十五个交易日后的三个月内，以大宗交易方式择机 减持其所持公司股份不超过 5,214,250 股，即不超过其持有公司股份总数的 25%， 不超过公司总股本的 1.7024%；以集中竞价方式减持其所持公司股份不超过 3,062,827 股，即不超过其持有公司股份总数的 25%且不超过公司总股本的 1%。 两种方式合计不超过 5,214,250 股。若减持计划期间公司有送股、资本公积金转 增股本等股份变动事项，本次拟减持股份数量将相应进行调整。 吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞 价交易择机减持其所持公司股份不超过 14,250 股，即不超过其持有公司股份 ...

Group 1 - The core point of the article is that the shareholder, Weng Kang, plans to reduce his holdings in Madi Technology by up to 5.2142 million shares, which represents 1.7% of the company's total share capital [1] - The reduction will occur within three months after the announcement and will include methods such as block trading and centralized bidding, with a maximum of 5.2142 million shares and 3.0628 million shares respectively [1] - Another shareholder, Wu Di, also plans to reduce his holdings by up to 14,300 shares, which is 0.0047% of the company's total share capital, within the same timeframe [1] Group 2 - The implementation of the reduction plans is subject to market conditions and the shareholders' financial arrangements, indicating a level of uncertainty [1]

Core Viewpoint - The announcement from MediTech (603990.SH) indicates that shareholders are planning to reduce their holdings, which may impact the stock's performance in the near term [1] Shareholder Reduction Details - Shareholder Weng Kang intends to reduce his holdings by up to 5,214,250 shares, representing approximately 1.7024% of the company's total share capital [1] - Shareholder Wu Di plans to reduce his holdings by up to 14,250 shares, which accounts for about 0.0047% of the company's total share capital [1] - The reduction period is set from October 16, 2025, to January 15, 2026 [1] - The reason for the reduction is stated as personal financial arrangements [1]

Core Viewpoint - The major shareholders of MediTech plan to reduce their holdings starting from October 16, 2025, through block trades and centralized bidding, indicating potential changes in ownership structure and liquidity concerns [1] Shareholder Reduction Plans - Shareholder Weng Kang intends to reduce holdings by up to 5.21 million shares through block trades, representing 1.70% of the total share capital [1] - Additionally, Weng Kang plans to sell up to 3.06 million shares via centralized bidding, accounting for 1% of the total share capital [1] - Board member Wu Di also plans to reduce holdings by up to 14,300 shares through block trades or centralized bidding, which is 0.0047% of the total share capital [1] Source of Shares and Reasons for Reduction - The shares to be reduced by both shareholders were acquired prior to the IPO and through centralized bidding transactions [1] - The reason for the reduction is stated as personal financial arrangements for both shareholders [1] Implementation Uncertainty - The implementation of the reduction plan is noted to have uncertainties, which may affect the timing and execution of the share sales [1]

吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞价交易择机减持其所持公司 股份不超过14,250股，即不超过其持有公司股份总数的25%，不超过公司总股本的0.0047%。 格隆汇9月16日丨麦迪科技(603990.SH)公布，翁康先生拟在本计划公告十五个交易日后的三个月内，以 大宗交易方式择机减持其所持公司股份不超过521.43万股，即不超过其持有公司股份总数的25%，不超 过公司总股本的1.7024%；以集中竞价方式减持其所持公司股份不超过306.28万股，即不超过其持有公 司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过521.44万股。 ...

Core Viewpoint - The announcement from MediTech (603990.SH) indicates that major shareholders plan to reduce their holdings through block trades and centralized bidding, which may impact the stock's liquidity and market perception [1] Summary by Categories Shareholder Reduction Plans - Shareholder Mr. Weng Kang intends to reduce his holdings by up to 5,214,250 shares within three months after the announcement, representing 25% of his total holdings and 1.7024% of the company's total share capital [1] - Mr. Wu Di plans to reduce his holdings by up to 14,250 shares within the same timeframe, which is also 25% of his total holdings and 0.0047% of the company's total share capital [1] Trading Methods - The reduction by Mr. Weng will occur through block trades and centralized bidding, with a maximum of 3,062,827 shares to be sold via centralized bidding, which is 1% of the company's total share capital [1] - The combined total reduction for both shareholders will not exceed 5,214,250 shares [1]

吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞价交易择机减持其所持公司 股份不超过14,250股，即不超过其持有公司股份总数的25%，不超过公司总股本的0.0047%。 麦迪科技（603990）(603990.SH)发布公告，股东翁康先生拟在本计划公告十五个交易日后的三个月 内，以大宗交易方式择机减持其所持公司股份不超过5,214,250股，即不超过其持有公司股份总数的 25%，不超过公司总股本的1.7024%;以集中竞价方式减持其所持公司股份不超过3,062,827股，即不超过 其持有公司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过5,214,250股。 ...